Latest News

Why Oatly Stock Zoomed Nearly 16% Higher This Weekfool.com

Via The Motley Fool · May 2, 2025

Why Investors Were Avoiding GeneDx Holdings Stock This Weekfool.com

Via The Motley Fool · May 2, 2025

Jobs Rise By 177,000 In April, 58,000 Negative Revisions In Preceding Monthstalkmarkets.com

The BLS beats the street again vs expectations of 130,000 jobs.

Via Talk Markets · May 2, 2025

11 Consumer Discretionary Stocks Moving In Friday's After-Market Sessionbenzinga.com

Via Benzinga · May 2, 2025

12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com

Via Benzinga · May 2, 2025

Paymentus Holdings's Earnings Outlookbenzinga.com

Via Benzinga · May 2, 2025

A Look Ahead: Vornado Realty's Earnings Forecastbenzinga.com

Via Benzinga · May 2, 2025

12 Industrials Stocks Moving In Friday's After-Market Sessionbenzinga.com

Via Benzinga · May 2, 2025

12 Information Technology Stocks Moving In Friday's After-Market Sessionbenzinga.com

Via Benzinga · May 2, 2025

Alnylam Delivers Q1 Surprise, Analysts Highlight Amvuttra Momentum, Limited Tariff Riskbenzinga.com

Alnylam analysts highlight Amvuttra's strong launch positioning and limited tariff risk, with bullish ratings maintained despite early launch volatility.

Via Benzinga · May 2, 2025

A Glimpse of Titan America's Earnings Potentialbenzinga.com

Via Benzinga · May 2, 2025

A Preview Of Sabra Health Care REIT's Earningsbenzinga.com

Via Benzinga · May 2, 2025

What's Next: Twist Bioscience's Earnings Previewbenzinga.com

Via Benzinga · May 2, 2025

An Overview of Freshpet's Earningsbenzinga.com

Via Benzinga · May 2, 2025

Insights into Black Stone Minerals's Upcoming Earningsbenzinga.com

Via Benzinga · May 2, 2025

What to Expect from Neurocrine Biosciences's Earningsbenzinga.com

Via Benzinga · May 2, 2025

Otter Tail's Earnings Outlookbenzinga.com

Via Benzinga · May 2, 2025

What 11 Analyst Ratings Have To Say About Glaukosbenzinga.com

Via Benzinga · May 2, 2025

An Overview of CRH's Earningsbenzinga.com

Via Benzinga · May 2, 2025

Earnings Outlook For Vertex Pharmaceuticalsbenzinga.com

Via Benzinga · May 2, 2025

Demystifying ITT: Insights From 6 Analyst Reviewsbenzinga.com

Via Benzinga · May 2, 2025

Demystifying PBF Energy: Insights From 12 Analyst Reviewsbenzinga.com

Via Benzinga · May 2, 2025

Breaking Down Hologic: 10 Analysts Share Their Viewsbenzinga.com

Via Benzinga · May 2, 2025

What 4 Analyst Ratings Have To Say About Axos Financialbenzinga.com

Via Benzinga · May 2, 2025

Beyond The Numbers: 4 Analysts Discuss FTC Solar Stockbenzinga.com

Via Benzinga · May 2, 2025